The conditions drug-exposed newborns experience during withdrawal



EFFICACY AND OUTCOMES OF A NON-PHARMACOLOGICAL INTERVENTION FOR NAS

SVS is being evaluated in a major NIH funded clinical study with infants exposed to drugs in the womb before birth.  Study enrollment is targeting 230 newborns with study completion in July 2021
Read More

VIBROTACTILE STIMULATION: A NON-PHARMACOLOGICAL INTERVENTION FOR OPIOID-EXPOSED NEWBORNS

SVS significantly reduced excessive body movements and improved the incidents of healthy breathing and heart rates. 
Read More

VIBRO‐TACTILE STIMULATION: A POTENTIAL THERAPEUTIC INTERVENTION FOR NAS

In the sample of 11 methadone/ buprenorphine exposed infants when SVS was turned on excessive body movements were reduced and the stability of healthy breathing improved.
Read More

PRAPELA WINS OHIO OPIOID TECHNOLOGY CHALLENGE

September 12, 2018

The Ohio Third Frontier Commission selected Prapela as a $200,000 Challenge Phase Winner.
Read More

NIH GRANT FOR NAS

September 05, 2018

Prapela submitted grant application "Prapela SVS: A cost-effective stochastic vibrotactile stimulation device to improve the clinical course of infants with neonatal abstinence syndrome"
Read More

APPLICATION TO FDA OPIOID USE DISORDER CHALLENGE

August 31, 2018

The "FDA Innovation Challenge: Devices to Prevent and Treat Opioid Use Disorder" was created to "to spur the development of medical devices" and other innovations to help combat the opioid crisis.
Read More

PRAPELA WINS NIDA "START A SUD START-UP CHALLENGE"

February 08, 2018

National Institute on Drug Abuse selected Prapela as an award winner.
Read More


Stay In Touch